{"id":"W2544907814","doi":"10.3324/haematol.2016.151126","title":"Primary analysis of a phase II open-label trial of INCB039110, a selective JAK1 inhibitor, in patients with myelofibrosis","year":2016,"lang":"en","type":"article","venue":"Haematologica","topic":"Myeloproliferative Neoplasms: Diagnosis and Treatment","field":"Medicine","cited_by":103,"is_retracted":false,"has_abstract":true,"ca_institutions":"University of British Columbia; St. Paul's Hospital; Princess Margaret Cancer Centre","funders":"National Cancer Institute; University of Texas MD Anderson Cancer Center; National Institutes of Health","keywords":"Myelofibrosis; Open label; Medicine; Ruxolitinib; Internal medicine; Oncology; Clinical trial; Pharmacology","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.002933546,0.001726167,0.00324279,0.0004132493,0.0004648771,0.001313144,0.0009511182,0.001125518,0.00377927],"category_scores_gemma":[0.001709694,0.0008265045,0.001768073,0.0005138745,0.001146986,0.0008982346,0.0004654286,0.003697451,0.001019156],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0009742638,"about_ca_system_score_gemma":0.002025316,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.000787887,"about_ca_topic_score_gemma":0.002516392,"domain_scores_codex":[0.9989244,0.0005923973,0.00005174474,0.0001648035,0.00009046743,0.0001759971],"domain_scores_gemma":[0.9981516,0.0003299406,0.0003424367,0.0001688392,0.0001335261,0.0008736327],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"nonrandomized_trial","study_design_scores_codex":[0.90796,0.03325245,0.003995809,0.0005259378,0.001169682,0.0001384098,0.00010925,0.001206029,0.0197258,0.0001508009,0.002106099,0.02965961],"study_design_scores_gemma":[0.7298734,0.2555738,0.00928847,0.00002453659,0.0005774752,0.0001363018,0.00003533296,0.0009726763,0.00205296,0.0001381069,0.001301232,0.0000257558],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.987823,0.002526043,0.001089366,0.0005668544,0.0001855667,0.003429556,0.002105387,0.0001419846,0.002132106],"genre_scores_gemma":[0.9870453,0.001327108,0.002064324,0.001084871,0.0002786149,0.003256119,0.003123077,0.0000369437,0.001783738],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.00377927,"threshold_uncertainty_score":0.01551425,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.02871582059334091,"score_gpt":0.3091379193859089,"score_spread":0.280422098792568,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}